Abstract
Summary
This report is an essential source for in-depth information and data relating
to the Brazil Patient Monitoring devices market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the Patient Monitoring in
Brazil
Scope
・ The report provides patient monitoring devices information broken down into
detailed categories and segments in Brazil.
・ Total revenues, products
sold, end users, and average pricing.
・ Market shares of all the key
competitors.
・ Key pipeline products that are set to shape the market,
broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the patient monitoring devices market in
Brazil.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table Of Contents 2
1.1 List of Tables 11
1.2 List of Figures 14
2 Introduction 17
2.1 What Is This Report About? 17
2.2 Definitions
17
2.2.1 Patient Monitoring 17
3 Healthcare Sector Review 19
3.1
Healthcare Expenditure 19
3.2 Healthcare Infrastructure 20
3.3
Healthcare Policy 20
4 Patient Monitoring in Brazil 21
4.1 Patient
Monitoring Overall Revenues (2000-2012) 21
4.2 Patient Monitoring Overall
Volume (2000-2012) 27
4.3 Patient Monitoring Overall Company Share
(2005-2006) 29
5 Multiparameter Patient Monitoring in Brazil 30
5.1
Multiparameter Patient Monitoring Overall Revenues (2000-2012) 30
5.1.1
Critical Care Monitors Overall Revenues (2000-2012) 34
5.1.2 Perioperative
Care Monitors Overall Revenues (2000-2012) 36
5.2 Multiparameter Patient
Monitoring Overall Volume (2000-2012) 38
5.2.1 Critical Care Monitors
Overall Volume (2000-2012) 40
5.2.2 Perioperative Care Monitors Overall
Volume (2000-2012) 42
5.3 Multiparameter Patient Monitoring Average Price
(2000-2012) 44
5.3.1 Critical Care Monitors Average Price (2000-2012)
44
5.3.2 Perioperative Care Monitors Average Price (2000-2012) 46
5.4
Multiparameter Patient Monitoring Distribution Share (2005-2006) 48
5.5
Multiparameter Patient Monitoring Company Share (2005-2006) 49
6
Non-Invasive Blood Pressure Monitors in Brazil 50
6.1 Non-Invasive Blood
Pressure Monitors Overall Revenues (2000-2012) 50
6.1.1 Automatic
Sphygmomanometer Overall Revenues (2000-2012) 54
6.1.2 Aneroid
Sphygmomanometer Overall Revenues (2000-2012) 56
6.1.3 Mercury
Sphygmomanometer Overall Revenues (2000-2012) 58
6.2 Non-Invasive Blood
Pressure Monitors Overall Volume (2000-2012) 60
6.2.1 Automatic
Sphygmomanometer Overall Volume (2000-2012) 62
6.2.2 Aneroid
Sphygmomanometer Overall Volume (2000-2012) 64
6.2.3 Mercury
Sphygmomanometer Overall Volume (2000-2012) 66
6.3 Non-Invasive Blood
Pressure Monitors Average Price (2000-2012) 68
6.3.1 Mercury
Sphygmomanometer Average Price (2000-2012) 68
6.3.2 Aneroid
Sphygmomanometer Average Price (2000-2012) 70
6.3.3 Automatic
Sphygmomanometer Average Price (2000-2012) 72
6.4 Non-Invasive Blood
Pressure Monitors Distribution Share (2005-2006) 74
6.5 Non-Invasive Blood
Pressure Monitors Company Share (2005-2006) 75
7 Wireless and Ambulatory
Monitoring in Brazil 76
7.1 Wireless and Ambulatory Monitoring Overall
Revenues (2000-2012) 76
7.1.1 Hospital Ambulatory Overall Revenues
(2000-2012) 80
7.1.2 Cardiac Rehabilitation Ambulatory Overall Revenues
(2000-2012) 82
7.2 Wireless and Ambulatory Monitoring Overall Volume
(2000-2012) 84
7.2.1 Hospital Ambulatory Overall Volume (2000-2012) 86
7.2.2 Cardiac Rehabilitation Ambulatory Overall Volume (2000-2012) 88
7.3
Wireless and Ambulatory Monitoring Average Price (2000-2012) 90
7.3.1
Hospital Ambulatory Average Price (2000-2012) 90
7.3.2 Cardiac
Rehabilitation Ambulatory Average Price (2000-2012) 92
7.4 Wireless and
Ambulatory Monitoring Distribution Share (2005-2006) 94
7.5 Wireless and
Ambulatory Monitoring Company Share (2005-2006) 95
8
Micro-Electromechanical Systems in Brazil 96
8.1 Micro-Electromechanical
Systems Overall Revenues (2000-2012) 96
8.2 Micro-Electromechanical
Systems Overall Volume (2000-2012) 98
8.3 Micro-Electromechanical Systems
Average Price (2000-2012) 100
8.4 Micro-Electromechanical Systems
Distribution Share (2005-2006) 102
8.5 Micro-Electromechanical Systems
Company Share (2005-2006) 103
9 Remote Patient Monitoring in Brazil
104
9.1 Remote Patient Monitoring Overall Revenues (2000-2012) 104
9.2
Remote Patient Monitoring Overall Volume (2000-2012) 106
9.3 Remote
Patient Monitoring Average Price (2000-2012) 108
9.4 Remote Patient
Monitoring Distribution Share (2005-2006) 110
9.5 Remote Patient
Monitoring Company Share (2005-2006) 111
10 GE Healthcare Company Profile
112
10.1 Company Overview 112
10.2 Business Overview 112
10.2.1
Products 113
10.3 Locations And Subsidiaries 114
10.4 Financial Deals
Landscape 116
10.4.1 GE Healthcare Acquires Image Diagnost International
116
10.4.2 GE Healthcare Acquires Dynamic Imaging 117
10.4.3 GE
Healthcare And The Medipattern Enter Into An Agreement 118
10.4.4 Ge
Healthcare Signs An Agreement With Nordiag 120
10.4.5 GE Healthcare And
Omron Healthcare Enter Into Distribution Agreement 121
10.4.6 GE
Healthcare Acquires Wave Biotech 122
10.4.7 PhotoCure enters into
licensing agreement with GE Healthcare 123
10.4.8 GE Healthcare And Awarix
Enter Into A Partnership Agreement 125
10.4.9 Ge Healthcare Signs An
Agreement With Applied Biosystems 126
10.4.10 Ge Healthcare Signs An
Agreement With Parker Domnick Hunter 127
10.4.11 BIOTRONIK Signs An
Agreement With GE Healthcare 129
10.4.12 GE Healthcare To Acquire Whatman
130
10.4.13 GE Healthcare terminates the acquisition of In vitro
diagnostics and Point-of-Care diagnostics businesses of Abbott 132
10.4.14
Abbott Terminates The Deal To Divest Its Divisions To GE Healthcare 134
10.5 Recent Developments 136
10.5.1 Dec 20, 2007: DRAXIMAGE Appoints GE
Healthcare As Distributor Of DRAXIMAGE(R) Sestamibi In US 136
10.5.2 Dec
18, 2007: Confirma Expands Strategic Partnership With GE Healthcare 137
10.5.3 Oct 10, 2007: GE Healthcare Appoints CTO 137
10.5.4 Jun 26, 2007:
Medipattern Signs Sales And Development Agreement With GE 138
10.5.5 Jun
01, 2007: I-Flow Forms Strategic Alliance With GE Healthcare 138
10.5.6
Apr 19, 2007: OMRON, GE Enter Distribution Agreement 139
10.6 GE
Healthcare Pipeline Products 141
10.6.1 Gemstone CT detector 141
10.6.2 Vivid e 08 141
10.6.3 LOGIQ e 142
10.6.4 Logiq Book XP
(Upgradation) 142
10.6.5 Modified lightSpeed VCT scanner 143
10.6.6
Responder 144
11 Philips Medical Systems Company Profile 146
11.1
Company Overview 146
11.2 Business Overview 146
11.2.1 Philips Medical
Systems 146
11.2.2 Products 148
11.2.3 History 150
11.3 Value
Chain Analysis 152
11.3.1 Manufacturing 152
11.3.2 Product Development
153
11.3.3 Sales and Marketing 153
11.3.4 SWOT Analysis 155
11.3.5
Philips Medical Systems Strengths 155
11.3.6 Philips Medical Systems
Weaknesses 156
11.3.7 Philips Medical Systems Opportunities 156
11.3.8
Philips Medical Systems Threats 157
11.4 Locations And Subsidiaries
158
11.5 Financial Deals Landscape 160
11.5.1 Philips Medical Acquires
Respironics 160
11.5.2 Philips Medical Acquires VISICU 161
11.5.3
Philips Medical Acquires Emergin 162
11.5.4 Philips Medical Acquires
VMI-Sistemas Medico 163
11.5.5 SHL Telemedicine Sells Raytel Cardiac
Services To Philips Medical 164
11.5.6 Philips Medical Acquires XIMIS
165
11.5.7 Philips Medical Acquires Health Watch Holdings 166
11.5.8
Philips Medical Signs An Agreement With Biosense 167
11.5.9 Philips
Medical Signs An Agreement With EP MedSystems 168
11.5.10 Philips Medical
Acquires Intermagnetics 169
11.5.11 Philips Medical Acquires Witt
Biomedical 170
11.5.12 Philips Medical Acquires Stentor 171
11.5.13
Philips Medical Forms A Joint Venture With Neusoft Digital Medical Systems
172
11.5.14 Philips Medical To Acquire TOMCAT Systems 173
11.6 Recent
Developments 175
11.6.1 Apr 03, 2008: Philips Signs Agreement With The
West China Hospital 175
11.6.2 May 07, 2007: Philips And Misys Collaborate
To Offer Technology Solution 175
11.6.3 Apr 26, 2007: Cardiac Science
Settles Patent Litigation With Philips 176
11.6.4 Jan 30, 2007: Philips
And Leading Healthcare Companies Join For Major Research And Development
176
11.6.5 Jan 29, 2007: Philips And Ascent Signs New Contract To Deliver
Digital Radiography Systems 176
11.6.6 Jun 19, 2006: Philips, UAB
Collaborate To Open New Heart And Vascular Center 177
11.7 Philips Medical
Systems Pipeline Products 178
11.7.1 Achieva 7.0T MRI Research System
178
11.7.2 MammoDiagnost DR 178
11.7.3 CliniScape - Mobile Clinical
Assistant 179
11.7.4 MammoTrak 180
11.7.5 iU22 ultrasound system
181
11.7.6 Practix Convenio DR 182
11.7.7 Eleva application in
DigitalDiagnost 182
11.7.8 Whobus system 183
11.7.9 Brilliance iCT
scanner (256-slice) 184
11.7.10 Wireless tracking system 185
12 Abbott
Laboratories 187
12.1 Company Overview 187
12.2 Business Overview
187
12.2.1 Products 189
12.2.2 History 191
12.3 Value Chain
Analysis 195
12.3.1 Manufacturing 195
12.3.2 Product Development
195
12.3.3 Sales and Marketing 197
12.4 SWOT Analysis 198
12.4.1
Abbott Laboratories Strengths 198
12.4.2 Abbott Laboratories Weaknesses
199
12.4.3 Abbott Laboratories Opportunities 199
12.4.4 Abbott
Laboratories Threats 200
12.5 Financial and Operational Review 201
12.5.1 Financial Statements 201
12.5.2 Financial Ratios 202
12.6
Locations And Subsidiaries 203
12.7 Financial Deals Landscape 205
12.7.1 Luminex Enters Into A Partnership Agreement With Abbott 205
12.7.2
Evalve Secures $60 Million In Series D Financing 206
12.7.3 Abbott
Acquires Kos Pharmaceuticals 208
12.7.4 Abbott Laboratories Enters Into An
Agreement With Enanta Pharmaceuticals 209
12.7.5 Abbott Laboratories
Enters Into Distribution Agreement With Verax 211
12.7.6 AstraZeneca Signs
An Agreement With Abbott 212
12.7.7 Abbott Laboratories Enters Into
Licensing Agreement With Advanced Life Science 214
12.7.8 Abbott Acquires
Vascular Business Of Guidant From Boston Scientific 215
12.7.9 Abbott
Enters Into An Agreement With Axis-Shield 217
12.7.10 Abbott Enters Into
Licensing Agreement With Nephromics 219
12.7.11 Abbott Enters Into
Licensing Agreement With BioCurex 220
12.7.12 Nihon Kohden And Abbott
Laboratories Enter Into Commercialization Agreement 221
12.7.13 Abbott
Signs An Agreement With OraSure 223
12.7.14 Abbott Enters Into Licensing
Agreement With Cleveland Clinic 224
12.7.15 Chattem Acquires Selsun Blue
226
12.7.16 Abbott Terminates The Deal To Divest Its Divisions To GE
Healthcare 227
12.7.17 GE Healthcare terminates the acquisition of In
vitro diagnostics and Point-of-Care diagnostics businesses of Abbott 229
12.8 Recent Developments 232
12.8.1 Apr 01, 2008: Abbott To Declare Q1
2008 Results 232
12.8.2 Jan 23, 2008: Abbott Declares Q4 2007 Results
232
12.8.3 Jan 03, 2008: Abbott To Declare Q4 And Year-End 2007 Results
232
12.8.4 Dec 14, 2007: Abbott Declares Quarterly Dividend 232
12.8.5
Oct 17, 2007: Abbott Declares Q3 2007 Results 233
12.8.6 Aug 03, 2007:
Abbott COO To Retire 233
12.8.7 Jul 18, 2007: Abbott Reports Q2 2007
Results 234
12.8.8 Jul 11, 2007: Abbott Announces Termination Of Contract
With GE 234
12.8.9 Jun 14, 2007: Abbott Declares Quarterly Dividend
235
12.8.10 Apr 18, 2007: Abbott Declares Quarterly Dividend 235
12.8.11 Apr 18, 2007: Abbott Reports Q1 2007 Results 235
12.8.12 Apr 10,
2007: Abbott Opens New Biotechnology Manufacturing Unit in Puerto Rico 236
12.8.13 Jan 24, 2007: Abbott Declares Quarterly Dividend 236
12.8.14 Jan
24, 2007: Abbott Reports Q4 2006 Results 236
12.8.15 Jan 08, 2007: Abbott
m2000・ Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada
237
12.8.16 Dec 20, 2006: Abbott To Voluntarily Delist From NYSE Arca
240
12.8.17 Oct 18, 2006: Abbott Announces Share Repurchase Program
240
12.8.18 Oct 18, 2006: Abbott Declares Quarterly Dividend 240
12.8.19 Oct 18, 2006: Abbott Reports Q3 2006 Results 240
12.8.20 Jul 19,
2006: Abbott Declares Quarterly Dividend 241
12.8.21 Jul 19, 2006: Abbott
Reports Q2 2006 Results 241
12.8.22 Apr 19, 2006: Abbott Declares
Quarterly Dividend 241
12.8.23 Apr 19, 2006: Abbott Reports Q1 2006
Results 242
12.8.24 Jan 20, 2006: Abbott Names New Director To The Board
242
12.9 Abbott Laboratories Pipeline Products 243
12.9.1 Fully
Bioabsorbable Stent 243
12.9.2 FreeStyle Navigator Continuous Glucose
Monitoring System 246
12.9.3 Wallis System 248
13 OMRON HEALTHCARE
Co., Ltd. Company Profile 251
13.1 Company Overview 251
13.2 Business
Overview 251
13.2.1 Products 251
13.3 Locations And Subsidiaries
253
13.4 Financial Deals Landscape 254
13.4.1 GE Healthcare And Omron
Healthcare Enter Into Distribution Agreement 254
13.4.2 The Carlyle Group
Sells Colin Medical Technology To OMRON 254
13.4.3 Omron Healthcare
Acquires Colin Medical Technology From The Carlyle Group 255
13.5 Recent
Developments 257
13.5.1 Feb 25, 2008: Omron Healthcare Names New COO
257
13.5.2 Feb 20, 2008: OMRON to Release New MEMS Mass Flow Sensor for
Fuel Cells 257
13.5.3 Jan 30, 2008: OMRON Announces Executive Personnel
Changes 258
13.5.4 Jan 30, 2008: OMRON Announces 75th Anniversary
Commemorative Dividend 258
13.5.5 Apr 19, 2007: OMRON, GE Enter
Distribution Agreement 259
13.5.6 Jun 29, 2006: OMRON Establishes New
Subsidiary In France 260
13.6 OMRON HEALTHCARE Co., Ltd. Pipeline Products
261
13.6.1 HEM-SOLAR blood pressure monitor-automatic upper-arm 261
13.6.2 HEM-SOLAR blood pressure monitor-manual upper-arm 262
13.6.3
HEM-SOLAR blood pressure monitor(automatic upper-arm) 263
14 Draegerwerk
Aktiengesellschaft Company Profile 265
14.1 Company Overview 265
14.2
Business Overview 265
14.2.1 Draeger Medical 265
14.2.2 Draeger Safety
265
14.2.3 Products 265
14.2.4 History 267
14.3 Value Chain
Analysis 269
14.3.1 Manufacturing 269
14.3.2 Product Development
270
14.3.3 Sales and Marketing 270
14.4 SWOT Analysis 271
14.4.1
Draegerwerk Aktiengesellschaft Strengths 271
14.4.2 Draegerwerk
Aktiengesellschaft Weaknesses 271
14.4.3 Draegerwerk Aktiengesellschaft
Opportunities 272
14.4.4 Draegerwerk Aktiengesellschaft Threats 272
14.5 Financial and Operational Review 273
14.6 Locations And Subsidiaries
275
14.7 Financial Deals Landscape 277
14.7.1 Draegerwerk Ag Acquires
10% Shares In Drager Medical From Siemens 277
14.7.2 Draegerwerk Ag
Acquires 10% Shares In Drager Medical From Siemens 278
14.7.3 Draeger
Medical Acquires Air-Shields Business from Hill-Rom 279
14.7.4 Aspect
Medical Systems Signs An Agreement With Draeger Medical Systems 280
14.8
Recent Developments 282
14.8.1 Mar 29, 2007: Draegerwerk Declares 2006
Results 282
15 Regulation System 284
15.1 Medical Device Registration
Protocol 284
15.1.1 Registration Documentation 284
15.1.2 Registration
Procedure 285
15.1.3 Medical Device Registration Fee 286
16 Pricing
and Reimbursement 287
17 Distribution Structure 288
18 APPENDIX
289
18.1 Global Markets Direct Research Methodology 289
18.2 Coverage
290
18.3 Secondary Research 290
18.4 Primary Research 291
18.5
Models 291
18.6 Forecasts 292
18.7 Expert Panels 292
18.8 Currency
Conversion 293
18.9 Contact Us 294
18.10 Disclaimer 294
